Abstract

465 Introduction Donor-specific blood transfusion has been shown to prolong allograft survival. We investigated the effect of hamster blood transfusion (HBT) on cardiac xenograft survival in rats. Methods T-cell deficient, athymic Nude rats and immunocompetent Lewis rats served as recipients of hamster cardiac xenografts. Heparinized hamster blood, 1 ml, was injected i.v. at day -7 and day -3 prior to transplantation at day 0. Lewis rats were treated with Cyclosporin A (CSA) at 10 mg/kg/day, or 20 mg/kg/day, starting at day -4. Antibody titers (ABT) were measured by flow cytometry, as mean% of positive controls, using hamster thymocytes as target cells.Results See table.Second hamster cardiac xenografts were accepted indefinitely, when transplanted to long-term surviving nude rats, indicating tolerance. Conclusion Pre-transplant HBT can induce tolerance in athymic nude rats, but leads to hyper acute rejection in immunocompetent Lewis rats. Low dose CSA can prevent sensitization and hyperacute rejection after HBT, and combination of HBT with high dose CSA even leads to prolonged survival of hamster cardiac xenografts in Lewis rats. Timing of HBT is of critical importance and the tolerogenic effects are specific for HBT, since a first hamster heart induced hyperacute rejection of a second hamster cardiac xenograft. Further elucidation of the mechanisms involved in this model will offer insight into induction of xenotransplant hyporesponsiveness.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.